NexImmune (NEXI) 10-K2023 FY Annual report

Filed: 16 Apr 24, 4:07pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: adjuvant, AFAB, alongside, Amtagvi, AON, ASCO, ATM, Bit, BMS, book, broker, buy, buyer, Cabaletta, carryforward, CDI, celiac, chairperson, circumstance, Clawback, CODM, cold, correlated, criterion, decade, deconvolution, Deploying, dimension, discerning, dissolve, DLT, downregulated, extramedullary, Forest, Gaza, Gracell, hardware, Herald, heterogeneity, hot, Ideal, immunosuppressive, inadvisable, induction, infiltrate, Inline, intercellular, intestate, intracellular, intrusion, Iridium, Jeff, Karverna, killer, Linkbase, Lisata, London, lympho, Lymphoblastic, MHC, MOA, modest, MPA, mRNA, multiplex, murine, neoantigen, network, NIST, penetrate, penetration, perpetrated, polyclonal, posture, predictor, pro, prompt, Quell, rata, reconvene, SAB, Sangamo, shell, shift, Simplification, stayed, steroid, Stover, Sucampo, tabletop, Taxonomy, TCE, TEAE, threat, Timothy, transient, Treg, triage, unintentional, unremediated, unwarranted, Wake, Warrant, warranted, washout, Weber, Wednesday, Wittenberg, XBRL

Removed: Academy, annum, Archigen, Assistant, attendance, Bank, BCF, Biochemistry, borrowed, Brunswick, CEO, Chase, combine, compelled, contractually, Cornell, correction, Corvidia, distinguishing, Downstate, enasidenib, essence, evidencing, evident, extinguishment, forgiven, Fujifilm, Gastroenterology, gastrointestinal, Greene, Greensboro, Harvard, hedging, hybrid, IMiD, Immodulon, immunochemistry, infection, invested, Janssen, JPMorgan, Kirin, Kyowa, leader, leasing, lenalidomide, load, loan, loaned, mortgage, movement, multiplied, NexGel, NJ, numerator, optional, package, partnering, Paycheck, Piedmont, PPP, precautionary, Professor, PTC, recession, remeasured, remeasurement, remotely, rest, retrospective, Sandoz, SBA, seniority, Soligenix, Sorrento, spent, SQZ, Suite, Summit, suspending, temporarily, thalidomide, thereon, trained, transactional, transporting, troubled, UCLA, undesignated, unrelated, unsecured, week, West, Wood

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

NEXI similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION UNDER SECTION 906

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of NexImmune, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge that:

The Annual Report for the year ended December 31, 2023 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: April 16, 2024	By:	/s/ Timothy Stover
		Timothy Stover Vice President, Corporate Controller (Principal Financial Officer and Principal Accounting Officer)